Low-transition rates in human immunodeficiency virus-infected adolescents: A cross-sectional mixed study of pediatric to adult care transition in Uganda

Table 2 Personal factors associated with transition into adulthood human immunodeficiency virus, n (%)

Variables (n = 261)	Category	Frequency/percent
Had a VL test in the last 2 years	No	5 (1.9)
	Yes	256 (98.1)
Recent VL results (copies)	< 1000	178 (68.2)
	≥ 1000	83 (31.8)
Reduction in current VL compared to previous VL results	No	81 (31.0)
	Yes	180 (69.0)
Time initiated on ART (months ago)	< 6	9 (3.4)
	6-12	58 (22.2)
	13-24	58 (22.2)
	Over 24	136 (52.1)
Ever had any treatment holiday	No	140 (53.6)
	Yes	121 (46.4)
Heard about transition care	No	44 (16.9)
	Yes	217 (83.1)
Source of information on transition	Fellow clients	44 (16.9)
	Adolescent clients	30 (11.5)
	Community	12 (4.6)
	Health worker	112 (42.9)
	Treatment supporter	63 (24.1)
Willingness to transition from adolescent ART care to adult care	No	87 (33.3)
	Yes	174 (66.7)
Time required to transition to adult care	Immediately	12 (4.6)
	≤ 1 week	2 (0.8)
	within 1 month	27 (10.3)
	within 6 months	47 (18)
	within 1 year	173 (66.3)
Components of TC	Transitioning team at adolescent clinic	48 (18.4)
	Transitioning plan once adult 18 years	189 (72.4)
	Adolescent’s readiness assessment > 2 years	10 (3.8)
	Appointment counselling sessions on TC	14 (5.4)
Benefits of transitioning to adult care	Retention in HIV care	13 (5.0)
	Continued ART adherence	75 (29.0)
	Successful viral suppression	126 (48.0)
	Partner HIV disclosure	371 (4.2)
	HIV care self-management	10 (3.8)
Stay with parent or relatives	No	53 (20.3)
	Yes	208 (79.7)
Person staying with if not parents or relative	Partner	15 (5.7)
	Friend	73 (28.0)
	Fellow client	1 (0.4)
	Well-wisher/organization	172 (65.9)
Have siblings	No	89 (34.1)
	Yes	172 (65.9)

ART: Antiretroviral therapy; HIV: Human immunodeficiency virus; TC: Transitioning care; VL: Viral load.